View : 612 Download: 0

High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology

Title
High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
Authors
Kong, Tae-WookKim, MiseonKim, Young-HanKim, Yong BeomKim, JayeonKim, Jae-WeonPark, Mi HyePark, Joo HyunRhee, Jeong HoLim, Myong CheolHong, Joon-Seok
Ewha Authors
박미혜
SCOPUS Author ID
박미혜scopusscopus
Issue Date
2020
Journal Title
JOURNAL OF GYNECOLOGIC ONCOLOGY
ISSN
2005-0380JCR Link

2005-0399JCR Link
Citation
JOURNAL OF GYNECOLOGIC ONCOLOGY vol. 31, no. 1
Keywords
Uterine Cervical NeoplasmsCancer Screening TestsHuman Papillomavirus DNA Tests
Publisher
KOREAN SOC GYNECOLOGY ONCOLOGY &

COLPOSCOPY
Indexed
SCIE; SCOPUS; KCI WOS scopus
Document Type
Article
Abstract
Based on emerging data and current knowledge regarding high-risk human papillomavirus (hrHPV) testing as a primary screening for cervical cancer, the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology support the following scientific facts: Compared to cytology, hrHPV screening has higher sensitivity and detects more cases of high-grade cervical intraepithelial neoplasia. Qualified hrHPV testing can be considered as an alternative primary screening for cervical cancer to the current cytology method. The starting age of primary hrHPV screening should not be before 25 years because of possible overtreatment in this age, which has a high human papillomavirus (HPV) prevalence but rarely progresses to cancer. The screening interval should be no sooner than every 3 years and no longer than every 5 years. Before the introduction of hrHPV screening in Korea, research into comparative effectiveness of primary hrHPV screening for cervical cancer should be conducted to determine the appropriate HPV assay, starting age, and screening interval.
DOI
10.3802/jgo.2020.31.e31
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE